{[ promptMessage ]}

Bookmark it

{[ promptMessage ]}

_Protocols_gog0212selections

_Protocols_gog0212selections - in women with advanced...

Info iconThis preview shows pages 1–6. Sign up to view the full content.

View Full Document Right Arrow Icon
GOG 0212 selections: A randomized Phase III trial of maintenance chemotherapy comparing 12 monthly cycles of single-agent paclitaxel or Xyotax (CT-2103) vs. no treatment until documented relapse
Background image of page 1

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full Document Right Arrow Icon
Background image of page 2
Background image of page 3

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full Document Right Arrow Icon
Background image of page 4
Background image of page 5

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full Document Right Arrow Icon
Background image of page 6
This is the end of the preview. Sign up to access the rest of the document.

Unformatted text preview: in women with advanced ovarian or primary peritoneal cancer who achieve a complete clinical response to primary platinum/ taxane therapy....
View Full Document

  • Winter '06
  • Tsodikov
  • Chemotherapy, paclitaxel, primary peritoneal cancer, complete clinical response, platinum/ taxane therapy, randomized Phase

{[ snackBarMessage ]}